Active Ingredient (In Each Extended-Release Bi-Layer Tablet)
Guaifenesin 600 mg
The following Structured Product Label (SPL) was submitted to the FDA by State Of Florida Doh Central Pharmacy for the product Mucinex (NDC 53808-0871). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient (in each extended-release bi-layer tablet), purpose, uses, directions, other information, inactive ingredients, keep out of reach of children, package label, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Guaifenesin 600 mg
Expectorant
helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive
Questions? 1-866-MUCINEX (1-866-682-4639)
You may also report side effects to this phone number
Please visit our web site www.mucinex.com
US Pat. 6,372,252 B1
US Pat. 6,955,821 B2
carbomer homopolymer type B, FD&C blue #1 aluminum lake; hypromellose, USP; magnesium stearate, NF; microcrystalline cellulose, NF; sodium starch glycolate, NF
Keep out of reach of children. This package is intended for institutional use only. This package is not child resistant. In case of overdose, get medical help or contact a Poison Control Center right away.
Label Image for 53808-0871
600mg
* Please review the disclaimer below.